Skip to main content
Helen Collins, MD, Oncology, Foster City, CA

HelenCollinsMD

Oncology • Foster City, CA

Physician

Join to view full profile

Dr. Collins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Collins' full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1992 - 1995
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1988 - 1991
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2026
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Prime Time for Five Prime as Amgen Snaps up This Once-Moribund Biotech for $1.9B and Its Phoenix-from-the-Flames Cancer Asset
    Prime Time for Five Prime as Amgen Snaps up This Once-Moribund Biotech for $1.9B and Its Phoenix-from-the-Flames Cancer AssetMarch 4th, 2021
  • Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ Gastric and GEJ Cancers
    Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ Gastric and GEJ CancersJanuary 15th, 2021
  • Five Prime Shares Triple in Value as Firm Meets All 3 Primary Endpoints in Phase 2 Gastric and GEJ Cancer Trial
    Five Prime Shares Triple in Value as Firm Meets All 3 Primary Endpoints in Phase 2 Gastric and GEJ Cancer TrialNovember 13th, 2020
  • Join now to see all

Dr. Helen Collins, Dr. Helen Collins, MD, Dr. H Collins